Company: PACB
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001299130-25-000090
Chunk: 83

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 83
---
1) |           |
| Name               |     | RSUs (#)                |           |
| Christian O. Henry |     |                         | 1,605,769 |
| Susan G. Kim(2)    |     |                         |   432,692 |
| Mark Van Oene      |     |                         |   798,076 |
| Jeff Eidel(3)      |     |                         |   461,538 |

(1) Represents awards granted under our 2020 Equity Incentive Plan.

(2) Ms. Kim served as our Chief Financial Officer until December 6, 2024, after which the unvested portion of her Annual Equity Grant RSU award terminated.

(3) Mr. Eidel served as our Chief Commercial Officer until November 15, 2024, after which the unvested portion of his Annual Equity Grant RSU award terminated.

Insider Trading Policy; Prohibition on Short Sales, Hedging & Pledging

We have adopted an insider trading policy governing the purchase, sale and other disposition of our securities by our directors, officers, and employees, including their immediate family members and certain other related parties. We believe our insider trading policy is reasonably designed to promote compliance with insider trading laws, rules and regulations and listing standards applicable to the Company. A copy of our insider trading policy is filed as Exhibit 19.1 to our Annual Report. Directors and employees of the Company, including executive officers, are prohibited by the Company’s Insider Trading Policyfrom: (1) engaging in short sales of Company securities; (2) engaging in transactions in publicly traded options, such as puts and calls, and other derivative securities with respect to the Company’s securities; (3) pledging Company securities as collateral for loans; and (4) holding the Company’s common stock in margin accounts.

Clawback Policy

During 2023, we adopted an updated clawback policy, effective October 2, 2023, for compliance with the Nasdaq Listing Rules and Section 10D of the Exchange Act. The policy generally requires us, in the event we are required to prepare an accounting restatement due to our material noncompliance with any financial reporting requirement under applicable securities laws, to recover certain incentive-based compensation made or granted to our NEOs and certain other current or former executive officers. Such incentive compensation generally includes compensation that is granted, earned or vested based in whole or in part on attaining performance goals relating to financial reporting measures, including any